| Information on regulating biocides in Northern Ireland |
| | | | Submit a notification by the deadline to keep active substances in the EU Review Programme. The European Chemicals Agency (ECHA) has published open invitations to provide an opportunity for a person, company or task force/consortium to notify an intention to take up or take over the role of participant in the EU Review Programme for the following active substance/product type combinations. This affects NI. Anyone wishing to support one of the active substance/product type combinations listed in the EU will need to submit a notification to ECHA by the following deadline: 4 November 2025 Terbutryn (CAS 886-50-0 EC 212-950-5) in product type 9 1,2-benzisothiazol-3(2H)-one (BIT) (CAS 2634-33-5 EC 220-120-9) in product type 9
If a notification to take over the role of participant is not received, these active substance/product type combinations will be subject to an EU non-approval decision. This means the active substances will no longer be able to be used in biocidal products of the relevant product types in NI.
In addition, articles treated with such products will no longer be able to be placed on the market in NI. HSE will provide separate updates on these where relevant. If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of the active substance/product type combinations listed, please contact us.
|
|
| | |
|
Health and Safety Executive - 2.2 Redgrave Court, Merton Road, Bootle, Merseyside L20 7HS
